CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.8236
5.69%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.0328
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.9336
Open* 1.9436
1-Year Change* -54.31%
Day's Range* 1.7636 - 1.9536
52 wk Range 1.46-5.72
Average Volume (10 days) 66.69K
Average Volume (3 months) 2.02M
Market Cap 28.87M
P/E Ratio -100.00K
Shares Outstanding 16.79M
Revenue N/A
EPS -3.65
Dividend (Yield %) N/A
Beta 0.85
Next Earnings Date Mar 13, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 16, 2024 1.9336 0.0200 1.05% 1.9136 1.9936 1.9136
Feb 15, 2024 1.9536 0.0200 1.03% 1.9336 1.9836 1.9236
Feb 14, 2024 1.9136 0.0500 2.68% 1.8636 1.9536 1.8636
Feb 13, 2024 1.8436 0.1000 5.74% 1.7436 1.9336 1.7436
Feb 12, 2024 1.7936 0.0500 2.87% 1.7436 1.9336 1.7336
Feb 9, 2024 1.7536 0.0000 0.00% 1.7536 1.7936 1.7136
Feb 8, 2024 1.7536 0.0500 2.93% 1.7036 1.8236 1.6736
Feb 7, 2024 1.7036 0.0000 0.00% 1.7036 1.7336 1.6936
Feb 6, 2024 1.7136 0.0400 2.39% 1.6736 1.7236 1.6736
Feb 5, 2024 1.6736 -0.0100 -0.59% 1.6836 1.7136 1.6736
Feb 2, 2024 1.7036 0.0100 0.59% 1.6936 1.7436 1.6936
Feb 1, 2024 1.7236 -0.0200 -1.15% 1.7436 1.7536 1.7136
Jan 31, 2024 1.7236 0.0100 0.58% 1.7136 1.7536 1.6936
Jan 30, 2024 1.6736 -0.0200 -1.18% 1.6936 1.7336 1.6636
Jan 29, 2024 1.7236 0.0300 1.77% 1.6936 1.7736 1.6936
Jan 26, 2024 1.7036 0.0300 1.79% 1.6736 1.7136 1.6736
Jan 25, 2024 1.6936 -0.0200 -1.17% 1.7136 1.7336 1.6736
Jan 24, 2024 1.6636 -0.0800 -4.59% 1.7436 1.7736 1.6436
Jan 23, 2024 1.7436 -0.0200 -1.13% 1.7636 1.7636 1.6936
Jan 22, 2024 1.7136 -0.0400 -2.28% 1.7536 1.7736 1.6636

Unity Biotech Events

Time (UTC) Country Event
Wednesday, March 13, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 UNITY Biotechnology Inc Earnings Release
Q4 2023 UNITY Biotechnology Inc Earnings Release

Forecast

-

Previous

-
Tuesday, May 7, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 UNITY Biotechnology Inc Earnings Release
Q1 2024 UNITY Biotechnology Inc Earnings Release

Forecast

-

Previous

-
Friday, June 21, 2024

Time (UTC)

16:00

Country

US

Event

UNITY Biotechnology Inc Annual Shareholders Meeting
UNITY Biotechnology Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0.236 4.784 0 0 0
Revenue 0.236 4.784 0 0
Total Operating Expense 57.608 61.249 93.93 89.651 79.465
Selling/General/Admin. Expenses, Total 20.949 23.056 24.025 20.046 16.016
Research & Development 36.859 38.393 67.309 70.957 58.907
Unusual Expense (Income) -0.2 -0.2 2.629 0
Operating Income -57.372 -56.465 -93.93 -89.651 -79.465
Interest Income (Expense), Net Non-Operating -2.338 -3.077 -0.096 3.289 3.312
Other, Net -0.217 -1.183 0.182 4.185 -0.245
Net Income Before Taxes -59.927 -60.725 -93.844 -82.177 -76.398
Net Income After Taxes -59.927 -60.725 -93.844 -82.177 -76.398
Net Income Before Extra. Items -59.927 -60.725 -93.844 -82.177 -76.398
Net Income -59.927 -60.725 -93.844 -82.177 -76.398
Income Available to Common Excl. Extra. Items -59.927 -60.725 -93.844 -82.177 -76.398
Income Available to Common Incl. Extra. Items -59.927 -60.725 -93.844 -82.177 -76.398
Diluted Net Income -59.927 -60.725 -93.844 -82.177 -76.398
Diluted Weighted Average Shares 9.49442 5.58159 5.08649 4.36248 2.82699
Diluted EPS Excluding Extraordinary Items -6.31181 -10.8795 -18.4497 -18.8372 -27.0245
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -6.33288 -10.9153 -17.9328 -18.8372 -27.0245
Total Extraordinary Items
Other Operating Expenses, Total 0 0 -0.033 -1.352 4.542
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0 0 0.236
Total Operating Expense 11.962 10.453 13.917 13.13 12.494
Selling/General/Admin. Expenses, Total 5.433 4.818 5.28 4.922 4.941
Research & Development 6.529 5.835 8.637 8.208 7.553
Unusual Expense (Income) -0.2 0
Other Operating Expenses, Total 0
Operating Income -11.962 -10.453 -13.917 -13.13 -12.258
Interest Income (Expense), Net Non-Operating -0.174 -0.147 -0.186 -0.537 -0.836
Other, Net -0.069 -0.265 -0.066 -0.041 -0.043
Net Income Before Taxes -12.205 -10.865 -14.169 -13.708 -13.137
Net Income After Taxes -12.205 -10.865 -14.169 -13.708 -13.137
Net Income Before Extra. Items -12.205 -10.865 -14.169 -13.708 -13.137
Net Income -12.205 -10.865 -14.169 -13.708 -13.137
Income Available to Common Excl. Extra. Items -12.205 -10.865 -14.169 -13.708 -13.137
Income Available to Common Incl. Extra. Items -12.205 -10.865 -14.169 -13.708 -13.137
Diluted Net Income -12.205 -10.865 -14.169 -13.708 -13.137
Diluted Weighted Average Shares 14.4258 14.3129 14.1915 10.0721 6.92478
Diluted EPS Excluding Extraordinary Items -0.84606 -0.75911 -0.99841 -1.36099 -1.8971
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.84606 -0.77308 -0.99841 -1.36099 -1.8971
Revenue 0 0 0 0.236
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 96.535 90.504 100.866 129.487 172.965
Cash and Short Term Investments 94.795 88.075 97.699 127.488 171.135
Cash & Equivalents 12.736 32.905 17.807 37.473 15.399
Short Term Investments 82.059 55.17 79.892 90.015 155.736
Total Receivables, Net 0
Accounts Receivable - Trade, Net 0
Prepaid Expenses 1.74 1.879 3.167 1.999 1.83
Total Assets 124.35 124.712 156.319 151.221 181.375
Property/Plant/Equipment, Total - Net 26.867 31.228 36.136 16.636 6.238
Property/Plant/Equipment, Total - Gross 39.621 43.486 45.878 22.952 9.888
Accumulated Depreciation, Total -12.754 -12.258 -9.742 -6.316 -3.65
Long Term Investments 0 1.993 17.871 3.025 0
Other Long Term Assets, Total 0.948 0.987 1.446 2.073 2.172
Total Current Liabilities 19.62 16.617 14.463 17.216 16.582
Accounts Payable 1.79 1.985 2.558 5.185 4.847
Accrued Expenses 8.354 10.398 11.905 9.006 7.92
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 1.179 0 2.98 3.737
Total Liabilities 57.502 65.143 73.439 30.514 20.682
Total Long Term Debt 10.891 18.409 24.508 0 0.046
Other Liabilities, Total 26.991 30.117 34.468 13.298 4.054
Total Equity 66.848 59.569 82.88 120.707 160.693
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.001 0.006 0.005 0.005 0.004
Additional Paid-In Capital 527.049 459.631 422.379 366.695 324.663
Retained Earnings (Accumulated Deficit) -459.951 -400.024 -339.299 -245.455 -163.278
Unrealized Gain (Loss) -0.251 -0.044 0.005 0.09 -0.095
Other Equity, Total 0 -0.21 -0.628 -0.601
Total Liabilities & Shareholders’ Equity 124.35 124.712 156.319 151.221 181.375
Total Common Shares Outstanding 14.2153 6.29919 5.32532 4.72271 4.24143
Current Port. of LT Debt/Capital Leases 9.476 3.055 0 0.045 0.078
Capital Lease Obligations 0 0.046
Long Term Debt 10.891 18.409 24.508
Other Current Assets, Total 0 0.55
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 49.538 72.966 86.381 96.535 102.724
Cash and Short Term Investments 45.939 69.092 83.392 94.795 98.94
Cash & Equivalents 7.876 19.118 22.972 12.736 22.576
Short Term Investments 38.063 49.974 60.42 82.059 76.364
Prepaid Expenses 3.599 3.874 2.989 1.74 3.234
Total Assets 69.27 101.008 114.255 124.35 136.393
Property/Plant/Equipment, Total - Net 18.836 25.242 26.053 26.867 27.717
Long Term Investments 1.899 0.896 0 4.98
Other Long Term Assets, Total 0.896 0.901 0.925 0.948 0.972
Total Current Liabilities 8.633 22.222 21.858 19.62 16.774
Accounts Payable 1.149 1.449 1.47 1.79 2.444
Accrued Expenses 7.484 7.069 7.326 8.354 7.554
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 13.704 13.062 9.476 6.776
Total Liabilities 33.064 51.601 55.627 57.502 57.828
Total Long Term Debt 0 4.082 7.619 10.891 13.262
Long Term Debt 0 4.082 7.619 10.891 13.262
Other Liabilities, Total 24.431 25.297 26.15 26.991 27.792
Total Equity 36.206 49.407 58.628 66.848 78.565
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.001 0.001 0.001 0.001 0.001
Additional Paid-In Capital 534.57 532.563 529.593 527.049 524.623
Retained Earnings (Accumulated Deficit) -498.31 -483.021 -470.816 -459.951 -445.784
Unrealized Gain (Loss) -0.055 -0.136 -0.15 -0.251 -0.275
Other Equity, Total
Total Liabilities & Shareholders’ Equity 69.27 101.008 114.255 124.35 136.393
Total Common Shares Outstanding 14.6149 14.5955 14.3592 14.2153 14.0363
Other Current Assets, Total 0 0.55
Other Current Liabilities, Total 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -60.725 -93.844 -82.177 -76.398 -44.656
Cash From Operating Activities -45.06 -78.333 -72.421 -56.623 -38.358
Cash From Operating Activities 2.88 3.449 2.663 2.18 1.304
Non-Cash Items 13.416 16.616 3.532 12.468 2.67
Changes in Working Capital -0.631 -4.554 3.561 5.127 2.324
Cash From Investing Activities 39.313 -5.208 67.953 -72.206 -86.305
Capital Expenditures -0.195 -0.646 -1.586 -1.264 -1.689
Other Investing Cash Flow Items, Total 39.508 -4.562 69.539 -70.942 -84.616
Cash From Financing Activities 20.845 63.875 27.438 136.93 42.775
Issuance (Retirement) of Stock, Net 20.703 39.356 27.511 139.31 42.83
Issuance (Retirement) of Debt, Net 0.142 24.519 -0.073 0.821 -0.055
Net Change in Cash 15.098 -19.666 22.97 8.101 -81.888
Financing Cash Flow Items 0 -3.201
Cash Interest Paid 2.37 0.773
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -18.915 -60.725 -50.032 -33.582 -15.756
Cash From Operating Activities -14.972 -45.06 -40.031 -28.475 -15.091
Cash From Operating Activities 0.627 2.88 2.209 1.501 0.757
Non-Cash Items 2.288 13.416 10.638 5.389 2.669
Cash Interest Paid 0.518 2.37 1.779 1.182 0.584
Changes in Working Capital 1.028 -0.631 -2.846 -1.783 -2.761
Cash From Investing Activities -5.817 39.313 30.235 13.083 14.062
Capital Expenditures 0 -0.195 -0.188 -0.09 -0.014
Other Investing Cash Flow Items, Total -5.817 39.508 30.423 13.173 14.076
Cash From Financing Activities 4.33 20.845 13.983 11.083 10.064
Issuance (Retirement) of Stock, Net 4.33 20.703 13.773 10.873 10.064
Issuance (Retirement) of Debt, Net 0.142 0.21 0.21 0
Net Change in Cash -16.459 15.098 4.187 -4.309 9.035
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
ARCH Venture Partners Venture Capital 6.8817 1004817 0 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.8555 562958 39034 2023-06-30 LOW
Empery Asset Management, L.P. Investment Advisor/Hedge Fund 3.0214 441165 441165 2022-09-30 LOW
UBS O'Connor LLC Hedge Fund 1.2265 179080 -33960 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8637 126108 3125 2023-06-30 LOW
Mayo Clinic Endowment Fund 0.8498 124081 -33117 2023-06-30
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.7687 112235 6706 2023-06-30 LOW
Laurion Capital Management LP Hedge Fund 0.4794 70000 0 2023-06-30 HIGH
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.4174 60947 -6952 2023-06-30 LOW
David (Nathaniel E) Individual Investor 0.4037 58939 -1 2023-04-24 LOW
Dananberg (Jamie) Individual Investor 0.3678 53701 5942 2023-04-24 LOW
Bridgeway Capital Management, LLC Investment Advisor 0.3424 50000 0 2023-06-30 MED
Founders Fund Venture Capital 0.3368 49172 0 2023-06-30 LOW
Wells Fargo Advisors Research Firm 0.2972 43402 43341 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 0.2909 42471 -35000 2023-06-30 HIGH
Cercano Management LLC Investment Advisor 0.2824 41238 0 2023-06-30
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.259 37824 -340 2023-06-30 LOW
Ghosh (Anirvan) Individual Investor 0.2575 37597 -1246 2023-09-14 MED
Morgan Stanley Smith Barney LLC Investment Advisor 0.1764 25757 -802 2023-06-30 LOW
Commonwealth Financial Network Investment Advisor 0.1668 24362 -10 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Unity Biotech Company profile

Unity Biotech
Industry: Bio Therapeutic Drugs

285 East Grand Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Oil - Crude

77.22 Price
-1.290% 1D Chg, %
Long position overnight fee 0.0081%
Short position overnight fee -0.0300%
Overnight fee time 22:00 (UTC)
Spread 0.030

Gold

2,028.10 Price
+0.500% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

52,206.85 Price
+0.490% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.56 Price
-1.270% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading